Page last updated: 2024-09-05

tesaglitazar and Skin Neoplasms

tesaglitazar has been researched along with Skin Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersson, U; Bamberg, K; Berg, AL; Blomgren, B; Camejo, G; Dahl, B; Dillner, B; Elebring, M; Evans, J; Hellmold, H; Holland, T; Lundholm, E; Roberts, R; Sjögren, N; Skånberg, I; Tugwood, J; Westerberg, R; Zhang, H	1

Other Studies

1 other study(ies) available for tesaglitazar and Skin Neoplasms

Article	Year
Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats. Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 98, Issue:1 Topics: Alkanesulfonates; Animals; Antimetabolites; Bromodeoxyuridine; Cholesterol; DNA; DNA Replication; Female; Fibrosarcoma; Hypoglycemic Agents; Immunohistochemistry; Male; Mesoderm; Microdissection; Organ Size; Phenylpropionates; PPAR alpha; PPAR gamma; Protein Binding; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Skin Neoplasms; Triglycerides	2007

Article

Year

Tesaglitazar, a PPARalpha/gamma agonist, induces interstitial mesenchymal cell DNA synthesis and fibrosarcomas in subcutaneous tissues in rats.

Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 98, Issue:1

Topics: Alkanesulfonates; Animals; Antimetabolites; Bromodeoxyuridine; Cholesterol; DNA; DNA Replication; Female; Fibrosarcoma; Hypoglycemic Agents; Immunohistochemistry; Male; Mesoderm; Microdissection; Organ Size; Phenylpropionates; PPAR alpha; PPAR gamma; Protein Binding; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA; Skin Neoplasms; Triglycerides

2007